Mirae Asset Global Etfs Holdings Ltd. Enochian Biosciences Inc Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 64,923 shares of ENOB stock, worth $298,645. This represents 0.0% of its overall portfolio holdings.
Number of Shares
64,923
Previous 23,627
174.78%
Holding current value
$298,645
Previous $108,000
175.93%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ENOB
# of Institutions
58Shares Held
19MCall Options Held
41.4KPut Options Held
49.2K-
Vanguard Group Inc Valley Forge, PA5.72MShares$26.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$16.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$10.7 Million0.0% of portfolio
-
State Street Corp Boston, MA2.06MShares$9.5 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL889KShares$4.09 Million0.0% of portfolio
About Enochian Biosciences Inc
- Ticker ENOB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,950,000
- Market Cap $244M
- Description
- Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...